Amy L. Billett, MD
Associate Professor of Pediatrics, Harvard Medical School
Center/ProgramPediatric Hematologic Malignancies
Office phone: 617-632-5640
Preferred contact method: office phone
View Physician Profile
Lymphoma (Hodgkin and Non-Hodgkin), Quality improvement, Patient safety, Electronic health records, Management of nausea and vomiting, Global health
Area of ResearchHodgkin's Disease in Children, CLABSI-reduction
Dana-Farber Cancer Institute
450 Brookline Avenue
Shields Warren 360
Boston, MA 02215
BiographyDr. Billett received her MD from Harvard Medical School in 1984. After completing a residency in pediatrics at the University of Washington Hospitals, she completed a fellowship in pediatric hematology-oncology at Children's Hospital Boston and Dana-Farber Cancer Institute and became a staff physician in the pediatric hematology/oncology program in 1990. She was the medical director of the inpatient oncology service at Children's Hospital 1995-2005.
Dr. Billett has participated in multiple projects involving improving systems of care, including development of a pediatric chemotherapy order entry system, implementation of the joint CH-DFCI pediatric electronic health record. She is currently the medical director for patient safety and quality in the pediatric hematology/oncology program, the leader of the pediatric lymphoma program, and an active clinician in the program.
She is a clinical faculty leader of the newly established national collaborative to reduce catheter-associated blood stream infections in pediatric hematology/oncology patients.
- Leadership Development for Physicians, Harvard Medical School, Boston, MA, 2003
ResearchHodgkin's Disease in Children, CLABSI-reduction
Our program has been an active member of a small national consortium for clinical trials in pediatric Hodgkins since 1990. pediatric Hodgkin's disease. We currently have three open trials looking at improving/maintaining efficacy while minimizing long-term toxicity.
Our center is a founding member of a national quality improvement collaborative started in 2009 to reduce catheter-associated blood stream infections in pediatric hematology-oncology patients. The focus of the collaborative is reliable implementation of best central line maintenance care.